Updated:
Major shareholders and company insiders disclosed a series of U.S. stock transactions in filings reported Tuesday, October 6, with purchases at Lifeway Foods and Sonic Automotive among the largest buys. Divisadero Street Capital Management reported more than $2.1 million in Lifeway purchases over three trading days, while Sonic director and 10% owner Paul Rusnak reported buying shares worth about $1.66 million.
The filings also included purchases at NexPoint Residential Trust, Grace Therapeutics and Willamette Valley Vineyards, alongside substantial sales at other companies. These disclosures record transactions and ownership changes; they do not, by themselves, establish why an insider traded or what the person expects the stock to do.
Lifeway stake increased through three purchases
Divisadero Street Capital Management acquired 17,482 Lifeway Foods shares on October 2 at $21.0885 each, 36,202 shares on October 5 at $21.0081, and 50,000 shares on October 6 at $20.8038. The combined reported value was approximately $2.17 million. After the purchases, the firm was reported to indirectly hold 2,451,792 shares.
The ownership disclosures identify the shares as held through Divisadero Street Partners, a fund managed by the investment adviser, rather than directly by the adviser. A Form 4 filing records the transactions as purchases. The figures describe the reported trades; they do not provide an explanation from the fund for its investment decisions.
Rusnak adds to Sonic Automotive holdings
Rusnak bought 27,756 Sonic Automotive shares on October 5 at $59.76 apiece, for a total of about $1.66 million. His direct holdings following the trade were reported at 5,149,401 shares. A separate disclosure of his earlier October 1 purchase showed another 21,645 shares bought at $59.50, indicating two reported purchases within a few days.
Investing.com’s contemporaneous coverage put Sonic shares near their reported 52-week low of $54.11 and said the stock had fallen about 15% over the prior year. That market comparison provides context for the timing, but it does not demonstrate that the price decline prompted the purchases.
Additional purchases disclosed
Matt McGraner, NexPoint Residential Trust’s executive vice president and chief investment officer, purchased 5,280 shares on October 1 at $18.89 and another 5,500 on October 5 at $18.42. The reported combined value was approximately $201,049, and his direct holdings after the transactions were listed as 361,604.6 shares. The reporting placed the stock near a 52-week low of $18.14, but the filings do not state McGraner’s rationale.
Opaleye Management, identified as a director and 10% owner of Grace Therapeutics, acquired 38,796 shares on October 1 at a weighted average price of $2.0353, for a reported total of about $123,819. Willamette Valley Vineyards director Gregory Voorhies bought 6,000 shares across October 2 and October 5 transactions, with prices ranging from $1.85 to $1.95 and an aggregate value of about $11,500.
Large sales also featured in the filings
The roundup also reported a roughly $721.6 million Medline share sale by GIC Private Ltd across several early-October transactions. On October 2, GIC directly sold 2,570,999 shares at a weighted average of $35.35, while an additional 7,146,941 shares were sold indirectly through Hux Investment Pte. Ltd. at $34.33 per share. The reported transactions spanned three dates, and the coverage did not provide a statement from GIC explaining the sales.
Apple Executive Chair Timothy Cook sold shares worth about $63.8 million on October 2, following the October 1 settlement of 374,541 restricted stock units. The report said Apple withheld 199,038 shares to cover tax obligations connected with the vesting. SentinelOne Chief Executive Tomer Weingarten also reported selling 527,368 Class A shares for about $13.32 million on October 5; the transaction was described as being made under a Rule 10b5-1 plan established July 2, 2026.
Filings document trades, not motives
Insider transaction reports can show the date, size and price of disclosed trades, along with holdings after a transaction. But a purchase may have many explanations, just as a sale may reflect circumstances unrelated to a company’s prospects. The reported filings and coverage offered no common explanation connecting the transactions across these unrelated companies.
The available reporting did not identify a further scheduled event tied to the trades. The disclosures therefore provide a record of recent insider activity, while the investors’ reasons and any subsequent investment decisions remain unknown.
